MPM ASSET MANAGEMENT LLC

Holdings History for Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA)

Symbol: TRDA on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025	57%	0%	$25,410,160	4,381,062	0		$5.80	Q3 2025
30 Jun 2025	68%	0%	$29,440,737	4,381,062	0		$6.72	Q2 2025
31 Mar 2025	57%	0%	$39,604,800	4,381,062	0		$9.04	Q1 2025
31 Dec 2024	61%	-0.62%	$75,748,562	4,381,062	-44,722	-1%	$17.29	Q4 2024
30 Sep 2024	49%	0%	$70,724,028	4,425,784	0		$15.98	Q3 2024
30 Jun 2024	35%	0%	$63,067,422	4,425,784	0		$14.25	Q2 2024
31 Mar 2024	26%	0%	$62,713,359	4,425,784	0		$14.17	Q1 2024
31 Dec 2023	33%	0%	$66,785,081	4,425,784	0		$15.09	Q4 2023
30 Sep 2023	37%	0%	$69,927,387	4,425,784	0		$15.80	Q3 2023
30 Jun 2023	33%	0%	$67,006,370	4,425,784	0		$15.14	Q2 2023
31 Mar 2023	27%	0%	$64,173,868	4,425,784	0		$14.50	Q1 2023
31 Dec 2022	25%	0%	$59,836,600	4,425,784	0		$13.52	Q4 2022
30 Sep 2022	27%	0%	$69,750,000	4,425,784	0		$15.76	Q3 2022
30 Jun 2022	23%	0%	$53,906,000	4,425,784	0		$12.18	Q2 2022
31 Mar 2022	14%	0%	$41,558,000	4,425,784	0		$9.39	Q1 2022
31 Dec 2021	16%	+16%	$75,769,000	4,425,784	+4,425,784	NEW	$17.12	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.